|
|
||||||||
RESEARCH COMMUNICATION |
a Rowett Research Institute, Bucksburn, Aberdeen AB21 9SB, United Kingdom
b Clínica Puerta de Hierro, Servicio de Nutrición, 28035-Madrid, Spain
c Institute of Food Research, Norwich Research Park, Colney, Norwich NR4 7UA, United Kingdom
| ABSTRACT |
|---|
|
|
|---|
Key Words: molecular epidemiology oxidative DNA damage coronary heart disease cancer
| INTRODUCTION |
|---|
|
|
|---|
| MATERIALS AND METHODS |
|---|
|
|
|---|
-tocopherol) was taken at 100 mg per day and carotenoids at 15 mg per day. `Palm oil carotenes' is a mixture of
- and ß-carotene (30 and 66.5%, respectively) and `lycopene' contains about 10% of ß-carotene. The study was approved by all relevant local ethics committees.
|
Sample preparation
Fasting venous blood samples were taken at weeks 0 and 16; lymphocytes were isolated by density gradient sedimentation (4) and slowly frozen in 90% fetal calf serum, 10% dimethylsulfoxide, to -80°C before storage in liquid nitrogen. Because the amount of blood available for this part of the investigation was insufficient to measure individual levels of 8-oxo-dG, lymphocytes from three or four subjects of the same sex from the same country and within the same supplementation group were combined; DNA was isolated by a high salt protein precipitation method (5). The DNA was hydrolyzed with deoxyribonuclease I, alkaline phosphatase, and phosphodiesterases I and II (6), and analyzed by high-performance liquid chromatography (HPLC) on a 15 x 0.46 cm Apex C18 3 µm column (Jones, Hengoed, Wales) with a 2 x 0.4 cm guard column containing Perisorb RP18 (Anachem, Luton, England). The mobile phase was 50 mM potassium phosphate, pH 5.5, with 7.5% methanol and the flow rate was 0.8 ml/min. Deoxyguanosine was measured using a Gilson Holochrome UV detector set at 254 nm. Detection of 8-oxo-dG required an electrochemical detector (Coulochem 5100H) with a 5021 conditioning cell and 5010 analytical cell. Three determinations were made on each hydrolyzed pooled sample, one of them including a spike of standard 8-oxo-dG, and the average of the two unspiked replicates was used in the calculation of mean values shown in the tables.
Antioxidant determinations
HPLC was used to measure vitamin C in acidified plasma (7) and vitamin E and carotenoids on nonacidified serum (8) from the same blood samples used for lymphocyte isolation.
Statistical analysis
Each set of data, for weeks 0 and 16, was subjected to analysis of variance (ANOVA) with factors `country', `sex', and (for week 16) `supplement'. Student's t test (two-tailed, assuming unequal variance) was used to compare means. Premature CHD mortality rates and cancer mortality rates (used to calculate correlations with 8-oxo-dG levels in
Table 4) were obtained from the WHO Database on Health Indicators, 1991.
|
RESULTS
Lymphocytes were available from France, Ireland, and Spain for analysis of DNA damage at week 0. ANOVA indicated a significant effect of sex (P<0.05) and of country (P<0.01). Similar levels of 8-oxo-dG occur in DNA from men and women from France and Spain and from women in Ireland, but there is significantly more in the samples from Irish men compared with women (
Table 1).
At week 16, after 12 wk of supplementation with carotenoid or placebo, we analyzed samples from France, Ireland, The Netherlands, and the U.K. ANOVA showed no effect of supplementation (P=0.74), but a significant effect of sex (P=0.01) with an interaction with country (P=0.06). Therefore the data were analyzed without reference to supplementation group (
Table 2).
Concentrations of 8-oxo-dG in men from Ireland and the U.K. are significantly elevated compared with those from France. No significant differences are seen between mean values for women in the four countries. In samples from Ireland, there is a particularly large difference in DNA damage between the sexes.
|
|
Concentrations of antioxidants are shown in
Table 3.
Overall, vitamin C concentrations are higher in women than in men (P<0.05). Concentrations of `total carotenoids' (i.e., lutein, zeaxanthin, lycopene, ß-cryptoxanthin,
- and ß-carotene) in serum from week 0 do not vary significantly between sexes or between countries. At week 16, mean serum carotenoid concentrations in France and Ireland (the two countries with pre- and postsupplementation samples) have increased as a result of 12 wk of supplementation, and are higher in women than in men (P<0.01). Serum vitamin E (not shown) does not vary significantly between countries or sexes at either week 0 or week 16.
|
DISCUSSION
This study represents the first international comparison of 8-oxo-dG levels as well as the first attempt to compare the sexes. As discussed elsewhere (9), estimates of the level of 8-oxo-dG in the DNA of human white blood cells have given a wide range of values, depending on the assay method as well as the precautions taken to avoid spurious oxidation of the sample DNA. The procedures used by us give low values for background levels of 8-oxo-dG (9). Differences in 8-oxo-dG between countries could conceivably result from subtle variations in the method of isolating cells (but not from different methods of isolating or hydrolyzing DNA, as this was done on all samples in one center). We believe this explanation to be unlikely, as a standard protocol was used by all participants in the study. Differences between men and women from the same center cannot be so explained, as the coded samples were treated in exactly the same way throughout.
It is evident that the highest levels of 8-oxo-dG are seen in the lymphocytes of men from northern Europe. Results for women in all five countries are indistinguishable. There is no obvious correspondence between levels of 8-oxo-dG and dietary antioxidant concentrations in blood. In the crucial case of the most extreme variationbetween men and women in Ireland at week 16vitamin C, vitamin E, and total carotenoid concentrations do not differ. Intrinsic antioxidant defences (glutathione, superoxide dismutase, and glutathione peroxidase) were also measured, and results will be published elsewhere; there were no consistent differences between the sexes and no association with levels of DNA damage.
On the basis of the supposed link between oxidative stress and certain human diseases, we looked for variations in patterns of incidence of various diseases that might reflect the variations in oxidative DNA damage.
Figure 2
illustrates the striking association between 8-oxo-dG concentrations and premature deaths from CHD (i.e., deaths in the age range of 064 years) in the five countries. The correlation coefficient (r) overall is 0.90. Taken separately, data for men have a correlation coefficient of 0.95, whereas mortality rates for women show no association with 8-oxo-dG levels. This is not surprising in view of the limited variation seen in the 8-oxo-dG concentrations for women. Note, too, that the measurements of DNA damage were made in premenopausal women (with very low CHD risk), whereas mortality figures reflect mainly postmenopausal CHD. On the basis of these data, we cannot say anything about the possibility of a link between CHD and oxidative stress in women; however, the ranking of countries in terms of CHD risk is the same for women as for men, suggesting that qualitatively similar factors operate in both sexes.
|
Correlations with cancer as well as CHD death rates are shown in
Table 4.
Overall cancer mortality is not associated with oxidative damage to DNA. Colorectal cancer in men is significantly positively correlated with 8-oxo-dG levels. However, the only other significant correlation is a negative one between stomach cancer and 8-oxo-dG in women. The hint of a difference in etiology of these diseases between men and women is intriguing.
High mean levels of oxidative DNA damage in lymphocytes from men in northern Europe do not reflect particularly low mean levels of plasma vitamin C, serum vitamin E, or carotenoids at the national level, as would have been predicted by the antioxidant hypothesis. Yet, as will be reported elsewhere, when individual values of DNA damage (measured by the more sensitive `comet assay') were assessed, we found significant negative correlations between DNA base oxidation and concentrations of carotenoids.
8-oxo-dG serves as a useful biomarker of oxidative stress. It may even have predictive value for CHD, but extensive studies of 8-oxo-dG concentrations in individuals (rather than mean values for population groups as estimated here) will be needed to determine the extent of inter- and intra-individual variability and to look for correlations with other risk factors. 8-oxo-dG appears less promising as an indicator of cancer risk.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
2 Abbreviations: CHD, coronary heart disease; ANOVA, analysis of variance; 8-oxo-dG, 8-oxo-deoxyguanosine; HPLC, high-performance liquid chromatography. ![]()
Received for publication January 15, 1998. Accepted for publication May 27, 1998.
| REFERENCES |
|---|
|
|
|---|
inská, M., Gedik, C. M., and
tetina, R. (1996) Oxidative damage to DNA: do we have a reliable biomarker? Environ. Health Perspect. Suppl. 3 104 465469
This article has been cited by other articles:
![]() |
X. Yang, S.-H. Liang, D. M. Weyant, P. Lazarus, C. J. Gallagher, and C. J. Omiecinski The Expression of Human Microsomal Epoxide Hydrolase Is Predominantly Driven by a Genetically Polymorphic Far Upstream Promoter J. Pharmacol. Exp. Ther., July 1, 2009; 330(1): 23 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Munch and M. Mangel Evaluation of mortality trajectories in evolutionary biodemography PNAS, October 31, 2006; 103(44): 16604 - 16607. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Siomek, A. Rytarowska, A. Szaflarska-Poplawska, D. Gackowski, R. Rozalski, T. Dziaman, M. Czerwionka-Szaflarska, and R. Olinski Helicobacter pylori infection is associated with oxidatively damaged DNA in human leukocytes and decreased level of urinary 8-oxo-7,8-dihydroguanine Carcinogenesis, March 1, 2006; 27(3): 405 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Astley and R. M. Elliott How Strong Is the Evidence that Lycopene Supplementation Can Modify Biomarkers of Oxidative Damage and DNA Repair in Human Lymphocytes? J. Nutr., August 1, 2005; 135(8): 2071S - 2073S. [Full Text] [PDF] |
||||
![]() |
D. D. Kennedy, R. M. Santella, Q. Wang, E. J. Ladas, and K. M. Kelly 8-oxo-dG Elevated in Children During Leukemia Treatment Integr Cancer Ther, December 1, 2004; 3(4): 301 - 309. [Abstract] [PDF] |
||||
![]() |
D. Gackowski, E. Speina, M. Zielinska, J. Kowalewski, R. Rozalski, A. Siomek, T. Paciorek, B. Tudek, and R. Olinski Products of Oxidative DNA Damage and Repair as Possible Biomarkers of Susceptibility to Lung Cancer Cancer Res., August 15, 2003; 63(16): 4899 - 4902. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ramakrishna, T. W Rooke, and L. T Cooper Iron and peripheral arterial disease: revisiting the iron hypothesis in a different light Vascular Medicine, August 1, 2003; 8(3): 203 - 210. [Abstract] [PDF] |
||||
![]() |
M. S. COOKE, M. D. EVANS, M. DIZDAROGLU, and J. LUNEC Oxidative DNA damage: mechanisms, mutation, and disease FASEB J, July 1, 2003; 17(10): 1195 - 1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Gedik, S. P. Boyle, S. G. Wood, N. J. Vaughan, and A. R. Collins Oxidative stress in humans: validation of biomarkers of DNA damage Carcinogenesis, September 1, 2002; 23(9): 1441 - 1446. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Giovannelli, C. Saieva, G. Masala, G. Testa, S. Salvini, V. Pitozzi, E. Riboli, P. Dolara, and D. Palli Nutritional and lifestyle determinants of DNA oxidative damage: a study in a Mediterranean population Carcinogenesis, September 1, 2002; 23(9): 1483 - 1489. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Merzenich, A. Hartwig, W. Ahrens, D. Beyersmann, R. Schlepegrell, M. Scholze, J. Timm, and K.-H. Jöckel Biomonitoring on Carcinogenic Metals and Oxidative DNA Damage in a Cross-Sectional Study Cancer Epidemiol. Biomarkers Prev., May 1, 2001; 10(5): 515 - 522. [Abstract] [Full Text] |
||||
![]() |
M. H. WILSON, P. J. GRANT, L. J. HARDIE, and C. P. WILD Glutathione S-transferase M1 null genotype is associated with a decreased risk of myocardial infarction FASEB J, April 1, 2000; 14(5): 791 - 796. [Abstract] [Full Text] |
||||
![]() |
F. Bianchini, S. Elmstahl, C. Martinez-Garcia, A.-L. van Kappel, T. Douki, J. Cadet, H. Ohshima, E. Riboli, and R. Kaaks Oxidative DNA damage in human lymphocytes: correlations with plasma levels of {alpha}-tocopherol and carotenoids Carcinogenesis, February 1, 2000; 21(2): 321 - 324. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |